about
Adjuvants: Classification, Modus Operandi, and LicensingPolyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytesInflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacySafety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasisNear-infrared laser adjuvant for influenza vaccineStability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solutionLaser vaccine adjuvants. History, progress, and potentialEvaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry.Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24GM-CSF and IL-2 as adjuvant enhance the immune effect of protein vaccine against foot-and-mouth disease.Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen.Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation.A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanismsClassification of Laser Vaccine AdjuvantsSemiconductor diode laser device adjuvanting intradermal vaccine.Disparate adjuvant properties among three formulations of "alum"Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.Adjuvant effects of saponins on animal immune responsesAdjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environmentEffective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.The ABC of clinical and experimental adjuvants--a brief overview.Working together: interactions between vaccine antigens and adjuvants.The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.Applications of chemokines as adjuvants for vaccine immunotherapy.Antivenom Production against Bothrops jararaca and Bothrops erythromelas Snake Venoms Using Cross-Linked Chitosan Nanoparticles as an Immunoadjuvant.A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice.Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants.
P2860
Q26747586-D32B4A1F-31FD-4A56-B75C-B08B39F334BBQ26852816-91876884-2CBB-44E8-8A5B-CE4930EC2B6AQ27488746-E09FC813-11C3-4F0D-A852-210F725C8867Q28480972-BD4AFB70-1F36-4227-B557-5DD535FC82F9Q28536886-30A8D282-D521-420C-855A-E880F0CB1F54Q30371202-AADE818B-92E8-4ABA-9C5C-F8E216171106Q30413501-0D54EED6-EF6A-442B-8D3F-15031A56F95AQ33368131-04C99B78-FB2D-4361-8053-5DD29C02C32DQ33743450-6473D2DC-0CF5-4E9A-9F2B-E4ACE67D40EBQ34510446-919A2EEA-3DC3-4032-86F8-BD445468EA28Q35682493-9B052F7B-A285-4AA9-BD3B-6670647216DCQ35831775-1F989BB9-4FB5-4464-811E-FC1F03C87440Q35895400-9FA307D8-5EB2-4884-B7B4-0B409116C6C0Q35996738-FDDE8861-A87B-4E81-BE76-A592EAE0553AQ36330880-6134ED14-F5E2-41DF-AD27-59586D2AA3D0Q36522053-16173B13-D77A-44D4-9C04-D36C633515ABQ36576750-37AFDCC1-3C88-419F-B634-8168E001B80AQ36745550-0B9582AC-FD0B-4AE4-B97A-706C0C72D15DQ36766169-8A72044B-4CA6-4B9F-AED2-5EC344F0F55BQ36804213-AFE7C723-0958-4209-AB94-5AA600CFA636Q37628867-0509E36D-89FA-41D1-A72F-D6CB3E5469E6Q37668409-32CF6494-C77B-4D53-BB48-8A2B2A2F330DQ38453147-A02B7ECD-56D7-4A89-AF4E-216DF3171B59Q40134053-998E2D4B-D7B7-41AE-B3D3-D4F3037BA031Q42265635-2DB54742-65C4-4ED3-8E48-96144FF07CADQ47288431-7CB430DC-1335-494A-BE68-2D9345AFB071Q52586171-76082E12-E3B9-4B82-8D09-0BD5F9F3A451Q55215825-F84FED91-48CD-45D5-9B67-0223F70CCBF7Q55380286-756FFDE0-2CEC-4587-85A7-47CF28D4EC5A
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Adjuvant properties of aluminum and calcium compounds.
@en
type
label
Adjuvant properties of aluminum and calcium compounds.
@en
prefLabel
Adjuvant properties of aluminum and calcium compounds.
@en
P2093
P1476
Adjuvant properties of aluminum and calcium compounds
@en
P2093
P304
P577
1995-01-01T00:00:00Z